Racura Oncology launches Phase I RC220 trial in Australia

Racura Oncology CEO and MD Daniel Tillett speaks with Proactive about the activation of the first Australian clinical site for the RC220 Phase I solid tumour trial. Dr Tillett confirms that the trial is now underway and open to patient enrolment.

Watch the full interview below. Additional report can be found here.